These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 19744288)

  • 21. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.
    Bernert S; Fernández A; Haro JM; König HH; Alonso J; Vilagut G; Sevilla-Dedieu C; de Graaf R; Matschinger H; Heider D; Angermeyer MC;
    Value Health; 2009; 12(5):750-8. PubMed ID: 19490564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Valuation of pemphigus vulgaris and pemphigus foliaceus health states: a convenience sample experiment.
    Rencz F; Brodszky V; Stalmeier PF; Tamási B; Kárpáti S; Péntek M; Baji P; Mitev AZ; Gulácsi L
    Br J Dermatol; 2016 Sep; 175(3):593-9. PubMed ID: 27062497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Test-retest reliability of health state valuation techniques: the time trade off and person trade off.
    Robinson S
    Health Econ; 2011 Nov; 20(11):1379-91. PubMed ID: 21053203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health state utilities for metastatic breast cancer in Taiwan.
    Chou TC; Chiang SC; Ko Y
    Breast; 2020 Jun; 51():57-64. PubMed ID: 32213442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protocols for time tradeoff valuations of health states worse than dead: a literature review.
    Tilling C; Devlin N; Tsuchiya A; Buckingham K
    Med Decis Making; 2010; 30(5):610-9. PubMed ID: 20068144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trends in the measurement of health utilities in published cost-utility analyses.
    Brauer CA; Rosen AB; Greenberg D; Neumann PJ
    Value Health; 2006; 9(4):213-8. PubMed ID: 16903990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health values of adolescents with cystic fibrosis.
    Yi MS; Britto MT; Wilmott RW; Kotagal UR; Eckman MH; Nielson DW; Kociela VL; Tsevat J
    J Pediatr; 2003 Feb; 142(2):133-40. PubMed ID: 12584533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interpretation of health and vision utilities in low vision patients.
    Malkin AG; Goldstein JE; Massof RW
    Optom Vis Sci; 2012 Mar; 89(3):288-95. PubMed ID: 22227913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Automated current health time-trade-off assessments in women's health.
    Tosteson AN; Kneeland TS; Nease RF; Sumner W
    Value Health; 2002; 5(2):98-105. PubMed ID: 11918825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quality of life utilities for pelvic inflammatory disease health states.
    Smith KJ; Tsevat J; Ness RB; Wiesenfeld HC; Roberts MS
    Sex Transm Dis; 2008 Mar; 35(3):307-11. PubMed ID: 18032995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimating an EQ-5D value set for Malaysia using time trade-off and visual analogue scale methods.
    Yusof FA; Goh A; Azmi S
    Value Health; 2012; 15(1 Suppl):S85-90. PubMed ID: 22265073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A theoretical framework for TTO valuations of health.
    Buckingham K; Devlin N
    Health Econ; 2006 Oct; 15(10):1149-54. PubMed ID: 16786547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deriving time discounting correction factors for TTO tariffs.
    Attema AE; Brouwer WB
    Health Econ; 2014 Apr; 23(4):410-25. PubMed ID: 23564665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Health outcomes in economic evaluation: who should value health?
    Stamuli E
    Br Med Bull; 2011; 97():197-210. PubMed ID: 21285110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of FACT- and EQ-5D-based utility scores in cancer.
    Pickard AS; Ray S; Ganguli A; Cella D
    Value Health; 2012; 15(2):305-11. PubMed ID: 22433762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Do individuals consider expected income when valuing health states?
    Davidson T; Levin LA
    Int J Technol Assess Health Care; 2008; 24(4):488-94. PubMed ID: 18828945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are people consistent when trading time for health?
    Oliver A; Wolff J
    Econ Hum Biol; 2014 Dec; 15():41-6. PubMed ID: 24953641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Valuation of depression co-occurring with a somatic condition: feasibility of the time trade-off task.
    Papageorgiou K; Vermeulen KM; Leijten FR; Buskens E; Ranchor AV; Schroevers MJ
    Health Expect; 2015 Dec; 18(6):3147-59. PubMed ID: 25393599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Feasibility and reliability of a mailed questionnaire to obtain visual analogue scale valuations for health states defined by the Health Utilities Index Mark 3.
    Raat H; Bonsel GJ; Hoogeveen WC; Essink-Bot ML;
    Med Care; 2004 Jan; 42(1):13-8. PubMed ID: 14713735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting time trade-off health state valuations of adolescents in four Pacific countries using the Assessment of Quality-of-Life (AQoL-6D) instrument.
    Moodie M; Richardson J; Rankin B; Iezzi A; Sinha K
    Value Health; 2010 Dec; 13(8):1014-27. PubMed ID: 20825621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.